A study published in Food & Function (2020) has shed new light on the potential health benefits of the Hericium erinaceus mushroom, commonly known as lion's mane. This research focused on examining the antioxidant properties of peptides derived from this mushroom and their potential anticancer effects.
Key Findings on Lion's Mane Anticancer Properties
- Antioxidant Activity: Researchers found that using 10 mg/mL Alcalase® for 4 hours produced the most effective antioxidants from lion's mane mushroom proteins.
- Potent Fraction Identified: The smallest protein fragments (less than 0.65 kDa in size) demonstrated the strongest antioxidant activity.
- DNA Protection: A specific fraction (F4) showed an ability to protect DNA from damage caused by harmful molecules.
- Anticancer Potential: The F4 fraction demonstrated an ability to slow the growth of lung cancer cells (Chago-K1) in laboratory tests.
- Mechanism of Action: The F4 fraction increased the activity of enzymes involved in programmed cell death (caspase-3, -8, and -9) in cancer cells.
Lion's Mane Cancer Research Implications
This research provides valuable insights into how compounds from the Hericium erinaceus mushroom might be used to develop new antioxidant supplements or potential cancer treatments. The study revealed that lion's mane peptides can scavenge free radicals and induce apoptosis in lung cancer cells in humans.
Future Directions for Lion's Mane Cancer Studies
While these findings on lion's mane anticancer potential are promising, it's important to note that these are preliminary results based on laboratory studies. More research, including human trials, would be needed to confirm these effects in the body and fully understand the anticancer properties of lion's mane mushroom.
References
